Ourotech makes personalized cancer treatment an exact science. We take tumor samples from patients and grow them into hundreds of micro-tumors inside a proprietary hydrogel that mimics tumor environemnt conditions inside the human body. We test different drugs on the tumors to see which drugs work best and which ones don't work, then tell the doctor/patient the most effective treatment plan for them. Our technology is ideal for mimicing late stage cancers (metastasis) and the goal of our company is to double the survival of late stage cancer patients from below 20% to 40%. We are currently entering preclinal trials and we will generate revenue by testing new drugs being developed for pharma companies while we go through the regulatory process for approval to use our technology in hospitals for personalized cancer treatment. We have 2 patents pending, 2 university pilot testers, 1 pharma company pilot and 1 hospital pilot in early 2017. We are raising $2 million USD.